Bank Of New York Mellon Corp Nevro Corp Transaction History

Bank Of New York Mellon Corp

$538 Trillion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$36.43 - $49.4 $4.44 Million - $6.02 Million	121,766 New	121,766 $4.82 Million
Q3 2022 Nov 14, 2022	SELL	$40.66 - $53.03 $7.46 Million - $9.73 Million	-183,483 Reduced 55.04%	149,854 $6.98 Million
Q2 2022 Aug 15, 2022	SELL	$40.85 - $77.67 $550,617 - $1.05 Million	-13,479 Reduced 3.89%	333,337 $14.6 Million
Q1 2022 May 11, 2022	SELL	$59.95 - $92.06 $709,808 - $1.09 Million	-11,840 Reduced 3.3%	346,816 $25.1 Million
Q4 2021 Feb 11, 2022	SELL	$81.07 - $121.29 $721,928 - $1.08 Million	-8,905 Reduced 2.42%	358,656 $29.1 Million
Q3 2021 Nov 12, 2021	BUY	$101.99 - $166.36 $548,706 - $895,016	5,380 Added 1.49%	367,561 $42.8 Million
Q2 2021 Aug 11, 2021	BUY	$141.6 - $179.06 $682,512 - $863,069	4,820 Added 1.35%	362,181 $60 Million
Q1 2021 May 13, 2021	BUY	$132.81 - $182.18 $948,927 - $1.3 Million	7,145 Added 2.04%	357,361 $49.9 Million
Q4 2020 Feb 09, 2021	BUY	$138.17 - $184.34 $1.22 Million - $1.63 Million	8,850 Added 2.59%	350,216 $60.6 Million
Q3 2020 Nov 12, 2020	BUY	$114.09 - $145.51 $629,434 - $802,778	5,517 Added 1.64%	341,366 $47.6 Million
Q2 2020 Aug 12, 2020	BUY	$89.45 - $129.85 $1.53 Million - $2.21 Million	17,054 Added 5.35%	335,849 $40.1 Million
Q1 2020 May 06, 2020	SELL	$70.23 - $144.31 $2.58 Million - $5.31 Million	-36,779 Reduced 10.34%	318,795 $31.9 Million
Q4 2019 Feb 14, 2020	SELL	$76.41 - $117.54 $13.6 Million - $20.9 Million	-177,988 Reduced 33.36%	355,574 $41.8 Million
Q3 2019 Nov 07, 2019	BUY	$61.52 - $91.1 $1.93 Million - $2.85 Million	31,314 Added 6.23%	533,562 $45.9 Million
Q2 2019 Aug 12, 2019	BUY	$58.04 - $66.99 $3.1 Million - $3.58 Million	53,476 Added 11.92%	502,248 $32.6 Million
Q1 2019 May 14, 2019	SELL	$35.52 - $62.62 $1.67 Million - $2.94 Million	-46,900 Reduced 9.46%	448,772 $28.1 Million
Q4 2018 Feb 11, 2019	BUY	$35.43 - $56.29 $677,563 - $1.08 Million	19,124 Added 4.01%	495,672 $19.3 Million
Q3 2018 Nov 09, 2018	BUY	$44.22 - $75.47 $2.74 Million - $4.68 Million	61,961 Added 14.95%	476,548 $0
Q2 2018 Aug 06, 2018	SELL	$72.38 - $92.5 $2.08 Million - $2.66 Million	-28,735 Reduced 6.48%	414,587 $33.1 Million
Q1 2018 May 15, 2018	BUY	$69.46 - $88.57 $4.78 Million - $6.1 Million	68,858 Added 18.39%	443,322 $38.4 Million
Q4 2017 Feb 09, 2018	BUY	$65.94 - $93.31 $24.7 Million - $34.9 Million	374,464	374,464 $25.9 Million

Others Institutions Holding NVRO

# of Institutions

151

Shares Held

39.3M

Call Options Held

67.9K

Put Options Held

1.59M

Arrow Mark Colorado Holdings LLC Denver, CO

4.39M
Shares

$16.6 Million
0.35% of portfolio
Armistice Capital, LLC New York, NY

3.73M
Shares

$14.1 Million
0.35% of portfolio
Black Rock Inc. New York, NY

3.6M
Shares

$13.6 Million
0.0% of portfolio
Glenn Welling Engaged Capital LLC | Newport Beach, Ca

2.44M
Shares

$9.21 Million
2.49% of portfolio
Vanguard Group Inc Valley Forge, PA

2.1M
Shares

$7.9 Million
0.0% of portfolio

View Full List

About NEVRO CORP

Ticker NVRO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,387,800
Market Cap $133M
Description
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...

More about NVRO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Account